Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors
Jeremy M. Richter(Bristol-Myers Squibb (Germany)), E. Scott Priestley(Bristol-Myers Squibb (United States)), Ruth R. Wexler(DuPont (United States)), Dietmar Seiffert(Bristol-Myers Squibb (United States)), Pancras C. Wong(Bristol-Myers Squibb (United States)), Joseph M. Luettgen(Bristol-Myers Squibb (United States)), Anzhi Wei(Bristol-Myers Squibb (United States)), Timothy M. Harper(Bristol-Myers Squibb (United States)), Rangaraj Narayanan(Bristol-Myers Squibb (United States)), Daniel L. Cheney(Bristol-Myers Squibb (United States)), Jay Bates(Bristol-Myers Squibb (United States)), Alan R. Rendina(Bristol-Myers Squibb (United States))
Cited by 6
Related Papers
MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
|Bioorganic & Medicinal Chemistry Letters|1998|406
Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and Welwitindolinones<i>via</i>a Redox Economic Approach
|Journal of the American Chemical Society|2008|283
Enantioselective Total Syntheses of Welwitindolinone A and Fischerindoles I and G
|Journal of the American Chemical Society|2005|273
Direct Coupling of Indoles with Carbonyl Compounds: Short, Enantioselective, Gram-Scale Synthetic Entry into the Hapalindole and Fischerindole Alkaloid Families
|Journal of the American Chemical Society|2004|249